FirstLook Lung is a blood-based test that helps identify lung cancer risk before or alongside LDCT, for USPSTF-eligible adults. From DELFI Diagnostics.
Amoolya Singh · Executive Officer · decision-maker
Susan Tousi · Executive Officer, Director · decision-maker
Lee-Ann Smith-Freeman · Executive Officer · decision-maker
Douglas Schenkel · Executive Officer · decision-maker
Careers mailbox is known
Sep 18
Hiring 1 new role, 2 closed in 14 days
Apr 27
Board appointment DELFI Diagnostics Appoints Charles Newton to Board of Directors · PRNewswire
Dec 1, 2025
Took on debt financing $34.3M · SEC Form D
Oct 10, 2023
Launched DELFI Diagnostics introduces FirstLook Lung blood test · Medical Device Network
2019
Founded
5 open
$151k stated pay, 5 roles
Explore Therapeutic Protein Libraries. For decades, therapeutic antibody discovery and optimization has been a shot in the Dark With the power of quantitative protein data at unprecedented throughput, we bring the best therapeutic candidates to Light.
No named decision-maker yet.
Careers mailbox is known
Sep 27
Posted a role Lead Instrument Software Engineer
1 open
$205k stated pay, 1 roles
Syntax Bio is a synthetic biology company programming the next generation of stem cell-derived therapies and organoids.
No named decision-maker yet.
Careers mailbox is known
Jun 23
Partnership Syntax Bio and Applied StemCell Announce Strategic Collaboration to Advance Stem Cell Innovation · YahooFinance
Jun 21
Raised a round Series A · YahooFinance
Discover the antibody reactome. Infinity Bio's MIPSA platform reveals past and ongoing immune responses across comprehensive human, viral, and environmental antigen libraries at population scale.
H. Larman · Executive Officer, Director · decision-maker
Joy Nassif · Executive Officer, Director · decision-maker
Caroline Popper · Director · decision-maker
Benjamin Larman · Executive Officer, Director · decision-maker
Careers mailbox is known
Mar 17
New executive Infinity Bio Appoints Brian McKelligon as Chief Executive Officer · businesswire.com
Jul 15, 2025
Launched Infinity Bio Launches EnviroSIGHT, the World's First Comprehensive Environmental Antibody Analysis Service · businesswire.com
Jun 13, 2025
Raised a round Venture round $5M · SEC Form D
2023
Founded
Building the world’s largest atlas of engineered protein interaction data. DeepSeq’s Function-First platform maps live-cell PPI physics to engineer drugs that go beyond simple binder prediction.
No named decision-maker yet.
No careers mailbox known
Cell sorters by NanoCellect, like the WOLF G2 microfluidic cell sorter, provide gentle sorting analysis for fragile cells. The VERLO cell sorter adds imaging cytometry.
No named decision-maker yet.
No careers mailbox known
Kodikaz is a breakthrough pre-clinical gene therapy biotech company. Kodikaz translates cell-recognition and genomic integration mechanisms into curative therapies. Our Zip-Code Technology ™ was discovered in the lab of our scientific founder Dr. Leon Bernal-Mizrachi, at Emory Medical School.
No named decision-maker yet.
No careers mailbox known
At Arbor Biotechnologies, we develop genetic medicines through our discovery of programmable DNA editors to enable curative outcomes for patients.
No named decision-maker yet.
No careers mailbox known
Sep 27
Posted 2 roles Director, Regulatory Affairs, Associate Scientist, Protein Engineering
2 open
$178k stated pay, 2 roles
Explore Lightcast’s next-generation platform for single-cell functional analysis. Uncover detailed insights into cellular behaviour to accelerate research, drug discovery, and diagnostic development.
No named decision-maker yet.
Careers mailbox is known
No named decision-maker yet.
Careers mailbox is known
Jun 2022
Went through Y Combinator
The next generation of genome-wide on- and off-target analysis in your own hands. Our INDUCE-seq platform provides precise off-target detection and genome-wide insights.
No named decision-maker yet.
Careers mailbox is known
Top of page Meet The Team We are a multi-talented team of trailblazers, driven to explore beyond the expected and empower world-enhancing change.
No named decision-maker yet.
Careers mailbox is known
Sep 26
Moved to Gusto
2017
Founded
Better crops, by design. NuCicer pairs natural diversity with predictive breeding to deliver better-tasting, more nutritious chickpea ingredients at scale.
Kathryn Cook · Executive Officer, Director · decision-maker
Douglas Cook · Executive Officer, Director · decision-maker
Carsten Boers · Director
Jerry Steiner · Director
Careers mailbox is known
Dec 13, 2024
Raised a round Venture round $13.8M · SEC Form D
2019
Founded
Mark Sylvester · Executive Officer · decision-maker
Elizabeth Moreno · Executive Officer · decision-maker
Jill Davies · Executive Officer, Director · decision-maker
Kristin Ashcraft · Executive Officer · decision-maker
No careers mailbox known
2025
Team shrank to 52 was 100 · US Form 5500 (plan participants)
Sep 10, 2024
Raised a round Venture round $75.3M · SEC Form D
2016
Founded
Iambic Therapeutics combines machine learning with automated chemistry to discover small molecule drugs. Its NeuralPLexer models predict how proteins and candidate molecules bind. The company advances its own oncology pipeline built with those tools.
Maeve Wang · Executive Officer, Director · decision-maker
Careers mailbox is known
Sep 23, 2024
Raised a round Convertible Note $75k · SEC Form D
2019
Founded
